IBDEI07W ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19236,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,19236,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,19236,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,19237,0)
 ;;=E10.649^^65^798^16
 ;;^UTILITY(U,$J,358.3,19237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19237,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,19237,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,19237,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,19238,0)
 ;;=E10.65^^65^798^14
 ;;^UTILITY(U,$J,358.3,19238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19238,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,19238,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,19238,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,19239,0)
 ;;=E10.69^^65^798^29
 ;;^UTILITY(U,$J,358.3,19239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19239,1,3,0)
 ;;=3^DM Type 1 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,19239,1,4,0)
 ;;=4^E10.69
 ;;^UTILITY(U,$J,358.3,19239,2)
 ;;=^5002624
 ;;^UTILITY(U,$J,358.3,19240,0)
 ;;=E10.8^^65^798^33
 ;;^UTILITY(U,$J,358.3,19240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19240,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,19240,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,19240,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,19241,0)
 ;;=E10.9^^65^798^34
 ;;^UTILITY(U,$J,358.3,19241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19241,1,3,0)
 ;;=3^DM Type 1 w/o Compl
 ;;^UTILITY(U,$J,358.3,19241,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,19241,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,19242,0)
 ;;=E10.620^^65^798^5
 ;;^UTILITY(U,$J,358.3,19242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19242,1,3,0)
 ;;=3^DM Type 1 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,19242,1,4,0)
 ;;=4^E10.620
 ;;^UTILITY(U,$J,358.3,19242,2)
 ;;=^5002615
 ;;^UTILITY(U,$J,358.3,19243,0)
 ;;=E10.36^^65^798^4
 ;;^UTILITY(U,$J,358.3,19243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19243,1,3,0)
 ;;=3^DM Type 1 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,19243,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,19243,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,19244,0)
 ;;=E10.621^^65^798^6
 ;;^UTILITY(U,$J,358.3,19244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19244,1,3,0)
 ;;=3^DM Type 1 w/ Diab Foot Ulcer
 ;;^UTILITY(U,$J,358.3,19244,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,19244,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,19245,0)
 ;;=E10.622^^65^798^28
 ;;^UTILITY(U,$J,358.3,19245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19245,1,3,0)
 ;;=3^DM Type 1 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,19245,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,19245,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,19246,0)
 ;;=E10.51^^65^798^32
 ;;^UTILITY(U,$J,358.3,19246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19246,1,3,0)
 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,19246,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,19246,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,19247,0)
 ;;=E10.52^^65^798^31
 ;;^UTILITY(U,$J,358.3,19247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19247,1,3,0)
 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,19247,1,4,0)
 ;;=4^E10.52
 ;;^UTILITY(U,$J,358.3,19247,2)
 ;;=^5002611
 ;;^UTILITY(U,$J,358.3,19248,0)
 ;;=E11.00^^65^799^19
 ;;^UTILITY(U,$J,358.3,19248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19248,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
 ;;^UTILITY(U,$J,358.3,19248,1,4,0)
 ;;=4^E11.00
 ;;^UTILITY(U,$J,358.3,19248,2)
 ;;=^5002627
 ;;^UTILITY(U,$J,358.3,19249,0)
 ;;=E11.01^^65^799^18
 ;;^UTILITY(U,$J,358.3,19249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19249,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
 ;;^UTILITY(U,$J,358.3,19249,1,4,0)
 ;;=4^E11.01
 ;;^UTILITY(U,$J,358.3,19249,2)
 ;;=^5002628
 ;;^UTILITY(U,$J,358.3,19250,0)
 ;;=E11.21^^65^799^7
 ;;^UTILITY(U,$J,358.3,19250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19250,1,3,0)
 ;;=3^DM Type 2 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,19250,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,19250,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,19251,0)
 ;;=E11.22^^65^799^3
 ;;^UTILITY(U,$J,358.3,19251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19251,1,3,0)
 ;;=3^DM Type 2 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,19251,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,19251,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,19252,0)
 ;;=E11.39^^65^799^28
 ;;^UTILITY(U,$J,358.3,19252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19252,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,19252,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,19252,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,19253,0)
 ;;=E11.41^^65^799^6
 ;;^UTILITY(U,$J,358.3,19253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19253,1,3,0)
 ;;=3^DM Type 2 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,19253,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,19253,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,19254,0)
 ;;=E11.42^^65^799^13
 ;;^UTILITY(U,$J,358.3,19254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19254,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,19254,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,19254,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,19255,0)
 ;;=E11.43^^65^799^2
 ;;^UTILITY(U,$J,358.3,19255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19255,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,19255,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,19255,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,19256,0)
 ;;=E11.44^^65^799^1
 ;;^UTILITY(U,$J,358.3,19256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19256,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,19256,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,19256,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,19257,0)
 ;;=E11.49^^65^799^8
 ;;^UTILITY(U,$J,358.3,19257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19257,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,19257,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,19257,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,19258,0)
 ;;=E11.59^^65^799^25
 ;;^UTILITY(U,$J,358.3,19258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19258,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,19258,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,19258,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,19259,0)
 ;;=E11.610^^65^799^9
 ;;^UTILITY(U,$J,358.3,19259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19259,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,19259,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,19259,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,19260,0)
 ;;=E11.618^^65^799^26
 ;;^UTILITY(U,$J,358.3,19260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19260,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,19260,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,19260,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,19261,0)
 ;;=E11.621^^65^799^16
 ;;^UTILITY(U,$J,358.3,19261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19261,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,19261,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,19261,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,19262,0)
 ;;=E11.622^^65^799^31
 ;;^UTILITY(U,$J,358.3,19262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19262,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,19262,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,19262,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,19263,0)
 ;;=E11.628^^65^799^30
 ;;^UTILITY(U,$J,358.3,19263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19263,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,19263,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,19263,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,19264,0)
 ;;=E11.630^^65^799^33
 ;;^UTILITY(U,$J,358.3,19264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19264,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,19264,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,19264,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,19265,0)
 ;;=E11.638^^65^799^29
 ;;^UTILITY(U,$J,358.3,19265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19265,1,3,0)
 ;;=3^DM Type 2 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,19265,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,19265,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,19266,0)
 ;;=E11.641^^65^799^20
 ;;^UTILITY(U,$J,358.3,19266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19266,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,19266,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,19266,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,19267,0)
 ;;=E11.649^^65^799^21
 ;;^UTILITY(U,$J,358.3,19267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19267,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,19267,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,19267,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,19268,0)
 ;;=E11.65^^65^799^17
 ;;^UTILITY(U,$J,358.3,19268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19268,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,19268,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,19268,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,19269,0)
 ;;=E11.69^^65^799^32
 ;;^UTILITY(U,$J,358.3,19269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19269,1,3,0)
 ;;=3^DM Type 2 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,19269,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,19269,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,19270,0)
 ;;=E11.8^^65^799^34
 ;;^UTILITY(U,$J,358.3,19270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19270,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,19270,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,19270,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,19271,0)
 ;;=E11.9^^65^799^35
 ;;^UTILITY(U,$J,358.3,19271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19271,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,19271,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,19271,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,19272,0)
 ;;=E11.29^^65^799^27
 ;;^UTILITY(U,$J,358.3,19272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19272,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,19272,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,19272,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,19273,0)
 ;;=E11.311^^65^799^14
 ;;^UTILITY(U,$J,358.3,19273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19273,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,19273,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,19273,2)
 ;;=E11.319^5002632
 ;;^UTILITY(U,$J,358.3,19274,0)
 ;;=E11.319^^65^799^15
 ;;^UTILITY(U,$J,358.3,19274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19274,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,19274,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,19274,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,19275,0)
 ;;=E11.3211^^65^799^22
 ;;^UTILITY(U,$J,358.3,19275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19275,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,19275,1,4,0)
 ;;=4^E11.3211
 ;;^UTILITY(U,$J,358.3,19275,2)
 ;;=^5138331
 ;;^UTILITY(U,$J,358.3,19276,0)
 ;;=E11.3212^^65^799^23
 ;;^UTILITY(U,$J,358.3,19276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19276,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,19276,1,4,0)
 ;;=4^E11.3212
 ;;^UTILITY(U,$J,358.3,19276,2)
 ;;=^5138332
 ;;^UTILITY(U,$J,358.3,19277,0)
 ;;=E11.3213^^65^799^24
 ;;^UTILITY(U,$J,358.3,19277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19277,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,19277,1,4,0)
 ;;=4^E11.3213
 ;;^UTILITY(U,$J,358.3,19277,2)
 ;;=^5138333
 ;;^UTILITY(U,$J,358.3,19278,0)
 ;;=E11.40^^65^799^10
 ;;^UTILITY(U,$J,358.3,19278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19278,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,19278,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,19278,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,19279,0)
 ;;=E11.51^^65^799^12
 ;;^UTILITY(U,$J,358.3,19279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19279,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,19279,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,19279,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,19280,0)
 ;;=E11.52^^65^799^11
 ;;^UTILITY(U,$J,358.3,19280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19280,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,19280,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,19280,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,19281,0)
 ;;=E11.620^^65^799^5
 ;;^UTILITY(U,$J,358.3,19281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19281,1,3,0)
 ;;=3^DM Type 2 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,19281,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,19281,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,19282,0)
 ;;=E11.36^^65^799^4
 ;;^UTILITY(U,$J,358.3,19282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19282,1,3,0)
 ;;=3^DM Type 2 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,19282,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,19282,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,19283,0)
 ;;=I10.^^65^800^1
 ;;^UTILITY(U,$J,358.3,19283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19283,1,3,0)
 ;;=3^Essential/Primary Hypertension
 ;;^UTILITY(U,$J,358.3,19283,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,19283,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,19284,0)
 ;;=I11.0^^65^800^12
 ;;^UTILITY(U,$J,358.3,19284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19284,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,19284,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,19284,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,19285,0)
 ;;=I11.9^^65^800^13
 ;;^UTILITY(U,$J,358.3,19285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19285,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,19285,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,19285,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,19286,0)
 ;;=I12.0^^65^800^5
 ;;^UTILITY(U,$J,358.3,19286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19286,1,3,0)
 ;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
 ;;^UTILITY(U,$J,358.3,19286,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,19286,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,19287,0)
 ;;=I12.9^^65^800^4
 ;;^UTILITY(U,$J,358.3,19287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19287,1,3,0)
 ;;=3^Hypertensive CKD w/ Stage 1-4 CKD
 ;;^UTILITY(U,$J,358.3,19287,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,19287,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,19288,0)
 ;;=I13.0^^65^800^8
 ;;^UTILITY(U,$J,358.3,19288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19288,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,19288,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,19288,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,19289,0)
 ;;=I13.10^^65^800^10
 ;;^UTILITY(U,$J,358.3,19289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19289,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,19289,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,19289,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,19290,0)
 ;;=I13.11^^65^800^11
 ;;^UTILITY(U,$J,358.3,19290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19290,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,19290,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,19290,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,19291,0)
 ;;=I13.2^^65^800^9
 ;;^UTILITY(U,$J,358.3,19291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19291,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,19291,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,19291,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,19292,0)
 ;;=I15.0^^65^800^15
 ;;^UTILITY(U,$J,358.3,19292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19292,1,3,0)
 ;;=3^Renovascular Hypertension
 ;;^UTILITY(U,$J,358.3,19292,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,19292,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,19293,0)
 ;;=I15.1^^65^800^3
 ;;^UTILITY(U,$J,358.3,19293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19293,1,3,0)
 ;;=3^Hypertension Secondary to Oth Renal Disorders
 ;;^UTILITY(U,$J,358.3,19293,1,4,0)
 ;;=4^I15.1
 ;;^UTILITY(U,$J,358.3,19293,2)
 ;;=^5007072
 ;;^UTILITY(U,$J,358.3,19294,0)
 ;;=I15.2^^65^800^2
 ;;^UTILITY(U,$J,358.3,19294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19294,1,3,0)
 ;;=3^Hypertension Secondary to Endocrine Disorders
 ;;^UTILITY(U,$J,358.3,19294,1,4,0)
 ;;=4^I15.2
 ;;^UTILITY(U,$J,358.3,19294,2)
 ;;=^5007073
 ;;^UTILITY(U,$J,358.3,19295,0)
 ;;=I15.8^^65^800^16
 ;;^UTILITY(U,$J,358.3,19295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19295,1,3,0)
 ;;=3^Secondary Hypertension,Oth
 ;;^UTILITY(U,$J,358.3,19295,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,19295,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,19296,0)
 ;;=I15.9^^65^800^17
 ;;^UTILITY(U,$J,358.3,19296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19296,1,3,0)
 ;;=3^Secondary Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,19296,1,4,0)
 ;;=4^I15.9
 ;;^UTILITY(U,$J,358.3,19296,2)
 ;;=^5007075
 ;;^UTILITY(U,$J,358.3,19297,0)
 ;;=I16.0^^65^800^14
 ;;^UTILITY(U,$J,358.3,19297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19297,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,19297,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,19297,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,19298,0)
 ;;=I16.1^^65^800^7
 ;;^UTILITY(U,$J,358.3,19298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19298,1,3,0)
 ;;=3^Hypertensive Emergency
 ;;^UTILITY(U,$J,358.3,19298,1,4,0)
 ;;=4^I16.1
 ;;^UTILITY(U,$J,358.3,19298,2)
 ;;=^8204721
 ;;^UTILITY(U,$J,358.3,19299,0)
 ;;=I16.9^^65^800^6
 ;;^UTILITY(U,$J,358.3,19299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19299,1,3,0)
 ;;=3^Hypertensive Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,19299,1,4,0)
 ;;=4^I16.9
 ;;^UTILITY(U,$J,358.3,19299,2)
 ;;=^5138600
 ;;^UTILITY(U,$J,358.3,19300,0)
 ;;=A07.0^^65^801^5
 ;;^UTILITY(U,$J,358.3,19300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19300,1,3,0)
 ;;=3^Balantidiasis
 ;;^UTILITY(U,$J,358.3,19300,1,4,0)
 ;;=4^A07.0
 ;;^UTILITY(U,$J,358.3,19300,2)
 ;;=^12533
 ;;^UTILITY(U,$J,358.3,19301,0)
 ;;=A07.1^^65^801^9
 ;;^UTILITY(U,$J,358.3,19301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19301,1,3,0)
 ;;=3^Giardiasis [lambliasis]
 ;;^UTILITY(U,$J,358.3,19301,1,4,0)
 ;;=4^A07.1
 ;;^UTILITY(U,$J,358.3,19301,2)
 ;;=^5000049
 ;;^UTILITY(U,$J,358.3,19302,0)
 ;;=A07.2^^65^801^7
 ;;^UTILITY(U,$J,358.3,19302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19302,1,3,0)
 ;;=3^Cryptosporidiosis
 ;;^UTILITY(U,$J,358.3,19302,1,4,0)
 ;;=4^A07.2
 ;;^UTILITY(U,$J,358.3,19302,2)
 ;;=^29629
 ;;^UTILITY(U,$J,358.3,19303,0)
 ;;=A07.3^^65^801^12
 ;;^UTILITY(U,$J,358.3,19303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19303,1,3,0)
 ;;=3^Isosporiasis
 ;;^UTILITY(U,$J,358.3,19303,1,4,0)
 ;;=4^A07.3
 ;;^UTILITY(U,$J,358.3,19303,2)
 ;;=^5000050
 ;;^UTILITY(U,$J,358.3,19304,0)
 ;;=A07.4^^65^801^8
 ;;^UTILITY(U,$J,358.3,19304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19304,1,3,0)
 ;;=3^Cyclosporiasis
